Trial design, site selection and recruitment, all tailored to the specific oncology indication. It’s what we do. Best.
It’s not just the wide spectrum of hematology and oncology-related therapeutic indications that we cover. It’s that we cover every aspect and phase of drug development for all of them, from small dose finding and proof-of-concept studies to study design, patient recruitment, and management of large, multinational trials involving hundreds of patients. And, of course, regulatory strategy and submission.